Price T Rowe Associates Inc Opti Nose, Inc. Transaction History

Price T Rowe Associates Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.17 - $1.94 $1,340 - $2,223	1,146 Added 6.55%	18,651 $28,000
Q4 2023 Feb 14, 2024	BUY	$1.02 - $1.47 $2,655 - $3,826	2,603 Added 17.47%	17,505 $23,000
Q3 2023 Nov 14, 2023	SELL	$0.93 - $1.38 $193,494 - $287,121	-208,059 Reduced 93.32%	14,902 $19,000
Q2 2023 Aug 14, 2023	BUY	$1.11 - $2.05 $247,486 - $457,070	222,961 New	222,961 $275,000

88.3M

Ticker OPTN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 83,277,504
Market Cap $31.6M
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.